Virus Diseases
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Plus TherapeuticsAUSTIN, TX
2 programsExposed to a SARS-CoV-2 infectionN/A1 trial
Exposed to a SARS-CoV-2 infectionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Plus TherapeuticsExposed to a SARS-CoV-2 infection
Plus TherapeuticsExposed to a SARS-CoV-2 infection
Clinical Trials (2)
Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)
Start: May 2022Est. completion: Jun 2023
N/ACompleted
Post-COVID-19 Monitoring in Routine Health Insurance Data
Start: Aug 2021Est. completion: Dec 2023
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space